Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report
Article in Experimental and Therapeutic Medicine (March 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in Experimental and Therapeutic Medicine (March 2024)
Article in Advances in Therapy (January 2024)
Article in Oncology Letters (December 2023)